Revolution Medicines Q3'26 Earnings Preview
Revolution Medicines is scheduled to report Q3'26 results on November 04 after the market closes, with EPS anticipated at (2.35) USD.
RVMD (Revolution Medicines, Inc.) is set to announce its Q3'26 results on November 04, after the market closes. The earnings are expected to be disclosed at 4:02 PM ET (9:02 PM UTC).For Q3'26, revenue estimate is 25.58 million USD with EPS (earnings per share) anticipated at (2.35) USD. Learn more…